Abstract
Background: ‘AgNOR’ represents Nucleolar Organiser Regions stained with silver which are related to cell proliferation rate and tumor malignant potential. The objective of this study was to evaluate the role of AgNOR in differentiating benign and precancerous lesions from cancerous lesions in both cervical smears and histology. Materials and Methods: This was a prospective study conducted at Manipal Teaching Hospital, from July 2005 to June 2007. Women of suspected cervical pathology and who underwent pap smears test followed by subsequent biopsy were included. There were 53 cases were included out of which 11 cases were of high grade squamous intraepithelial lesion and 12 cases of low grade squamous intraepithelial lesion, and 10 cases each of carcinoma, chronic cervicitis with and without squamous metaplasia. Results: In Low grade squamous intraepithelial lesion meanAgNOR dots was < (2.9 in pap smears and 1.9 in histology) in high grade lesion (3.45 in pap smears and 3.00 in histology). In carcinoma meanAgNOR dots was 5.18 and 4.05 in pap smears and histology respectively. Subjective AgNOR Pattern Assessment in pap smears and in histology was increasing with significant difference from intraepithelial lesions to carcinoma. Conclusion: In cervical pathology, the number and shape of AgNOR dots change from benign to precancerous to malignant tumors. Similarly, AgNOR Pattern Assessment is useful in differentiating benign to intraepithelial lesions to carcinoma cases. DOI: http://dx.doi.org/10.3126/jpn.v2i3.6017 JPN 2012; 2(3): 180-185
Highlights
Cervical cancer is the second most common cancer in women of reproductive age group and is considered to arise from cervical intraepithelial neoplasia (CIN)
Many studies have reported a high prevalence of high-risk Human papillomavirus (HPV) types in high-grade CIN and squamous cell carcinoma.[2]
The aim of this study was to evaluate the role of AgNOR in differentiating benign and precancerous lesions from cancerous lesions in both cervical smears and histology
Summary
Cervical cancer is the second most common cancer in women of reproductive age group and is considered to arise from cervical intraepithelial neoplasia (CIN). Screening using cervical smears has long been established as a mainstay for detecting early cytological abnormalities and has contributed to a significant reduction in death from cervical cancer in many countries.[1]. Correspondence: Human papillomavirus (HPV) is known as the most important factor in the mechanism of oncogenesis of cervical cancer. Many studies have reported a high prevalence of high-risk HPV types in high-grade CIN and squamous cell carcinoma.[2]. Detection and treatment of precancerous lesions can prevent the progression to cervical cancer.[3] Identification of precancerous lesions has been done primarily by cytologic screening of cervical cells.[4]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
